|S-1/AOct 20, 5:28 PM ET

Tvardi Therapeutics, Inc. S-1/A

S-1/A · Tvardi Therapeutics, Inc. · Filed Oct 20, 2025

Documents

18 files
  • S-1
  • EX-23.1
  • GRAPHIC
    lg_tvardi-4clr.jpg

    GRAPHIC

  • GRAPHIC
    tb_pipeline-4c.jpg

    GRAPHIC

  • GRAPHIC
    ph_canonicalfunction-4c.jpg

    GRAPHIC

  • GRAPHIC
    ph_dualmechanism-4c.jpg

    GRAPHIC

  • GRAPHIC
    ph_fibroticcascade-4c.jpg

    GRAPHIC

  • GRAPHIC
    ph_indsubmission-4c.jpg

    GRAPHIC

  • GRAPHIC
    ph_majorcompartments-4clr.jpg

    GRAPHIC

  • GRAPHIC
    ph_lungfibrosis-4clr.jpg

    GRAPHIC

  • GRAPHIC
    bc_impactonboth-4c.jpg

    GRAPHIC

  • GRAPHIC
    bc_demonstrateddose-4c.jpg

    GRAPHIC

  • GRAPHIC
    fc_ipftherapies-4clr.jpg

    GRAPHIC

  • GRAPHIC
    fc_phase2clinical-4c.jpg

    GRAPHIC

  • GRAPHIC
    ph_nashinduced-4clr.jpg

    GRAPHIC

  • GRAPHIC
    ph_hccpdxtumor-4clr.jpg

    GRAPHIC

  • GRAPHIC
    ph_tumortrajectories-4c.jpg

    GRAPHIC

  • GRAPHIC
    fc_phase1clinical-4c.jpg

    GRAPHIC